These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 14984818

  • 21. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model.
    Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM.
    J Allergy Clin Immunol; 2001 Jul; 108(1):39-46. PubMed ID: 11447380
    [Abstract] [Full Text] [Related]

  • 22. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
    Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF.
    J Clin Pharm Ther; 2006 Aug; 31(4):363-8. PubMed ID: 16882106
    [Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
    Hjelmgren J, Svensson A, Jörgensen ET, Lindemalm-Lundstam B, Ragnarson Tennvall G.
    Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
    [Abstract] [Full Text] [Related]

  • 24. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A, Ward NS.
    Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
    [Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density.
    Fuhlbrigge AL, Bae SJ, Weiss ST, Kuntz KM, Paltiel AD.
    J Allergy Clin Immunol; 2006 Feb; 117(2):359-66. PubMed ID: 16461137
    [Abstract] [Full Text] [Related]

  • 26. [Do inhaled corticosteroids reduce mortality in chronic obstructive pulmonary disease?].
    Bridevaux PO, Leuenberger P.
    Rev Med Suisse; 2005 Nov 16; 1(41):2673-4, 2677-9. PubMed ID: 16355882
    [Abstract] [Full Text] [Related]

  • 27. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S, Decramer M, Laekeman G.
    Respir Med; 2007 Jan 16; 101(1):15-26. PubMed ID: 16650975
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease.
    Chuck A, Jacobs P, Mayers I, Marciniuk D.
    Can Respir J; 2008 Jan 16; 15(8):437-43. PubMed ID: 19107245
    [Abstract] [Full Text] [Related]

  • 29. Contemporary opinions on administration of inhaled glucocorticosteroids in the treatment of chronic obstructive pulmonary disease.
    Podstawka A, Mosiewicz J, Myśliński W.
    Ann Univ Mariae Curie Sklodowska Med; 2004 Jan 16; 59(2):491-7. PubMed ID: 16146136
    [Abstract] [Full Text] [Related]

  • 30. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians.
    Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK, Clinical Efficacy Assessment Subcommittee of the American College of Physicians.
    Ann Intern Med; 2007 Nov 06; 147(9):633-8. PubMed ID: 17975186
    [Abstract] [Full Text] [Related]

  • 31. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Selroos O.
    Curr Med Res Opin; 2004 Oct 06; 20(10):1579-93. PubMed ID: 15462691
    [Abstract] [Full Text] [Related]

  • 32. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar 06; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease.
    Oba Y.
    Am J Manag Care; 2009 Feb 06; 15(2):97-104. PubMed ID: 19284806
    [Abstract] [Full Text] [Related]

  • 34. Translating Pharmacometrics to a Pharmacoeconomic Model of COPD.
    Slejko JF, Willke RJ, Ribbing J, Milligan P.
    Value Health; 2016 Dec 06; 19(8):1026-1032. PubMed ID: 27987629
    [Abstract] [Full Text] [Related]

  • 35. [Clinical efficacy of inhaled corticosteroids in COPD].
    Kamoi H, Yoshikawa T, Hirata K.
    Nihon Rinsho; 2007 Apr 06; 65(4):696-701. PubMed ID: 17419390
    [Abstract] [Full Text] [Related]

  • 36. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].
    Nishimura K.
    Nihon Rinsho; 2003 Dec 06; 61(12):2181-6. PubMed ID: 14674330
    [Abstract] [Full Text] [Related]

  • 37. [The choice and administration of corticoids in COPD].
    Yernault JC, Sternon J.
    Rev Med Brux; 2002 Apr 06; 23(2):96-101. PubMed ID: 12056065
    [Abstract] [Full Text] [Related]

  • 38. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder.
    Chen S, Plauschinat CA, Wu N, Fraser K, Boulanger L.
    J Med Econ; 2011 Apr 06; 14(4):458-62. PubMed ID: 21651427
    [Abstract] [Full Text] [Related]

  • 39. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.
    Am J Respir Crit Care Med; 2003 Dec 15; 168(12):1488-94. PubMed ID: 14525798
    [Abstract] [Full Text] [Related]

  • 40. Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations.
    van der Schans S, Goossens LMA, Boland MRS, Kocks JWH, Postma MJ, van Boven JFM, Rutten-van Mölken MPMH.
    Pharmacoeconomics; 2017 Jan 15; 35(1):43-63. PubMed ID: 27592021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.